AR009600A1 - SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME. - Google Patents
SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME.Info
- Publication number
- AR009600A1 AR009600A1 ARP970105002A ARP970105002A AR009600A1 AR 009600 A1 AR009600 A1 AR 009600A1 AR P970105002 A ARP970105002 A AR P970105002A AR P970105002 A ARP970105002 A AR P970105002A AR 009600 A1 AR009600 A1 AR 009600A1
- Authority
- AR
- Argentina
- Prior art keywords
- sequence
- vaccine compositions
- nucleic acid
- amino acids
- same
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000590002 Helicobacter pylori Species 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 title 1
- 229940037467 helicobacter pylori Drugs 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Se describen preparaciones recombinantes o sustancialmente puras de polipéptidos de H.pylori. Los ácidos nucleicos que codifican a lospolipéptidos también se describen. Los polipéptidos de H.pylori son utiles para el diagnotico y lascom posiciones para vacuna.Recombinant or substantially pure preparations of H.pylori polypeptides are described. Nucleic acids encoding polypeptides are also described. H.pylori polypeptides are useful for diagnosis and vaccine compositions.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73915096A | 1996-10-28 | 1996-10-28 | |
| US75973996A | 1996-12-06 | 1996-12-06 | |
| US89192897A | 1997-07-14 | 1997-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR009600A1 true AR009600A1 (en) | 2000-04-26 |
Family
ID=27419246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970105002A AR009600A1 (en) | 1996-10-28 | 1997-10-28 | SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0973394A4 (en) |
| JP (1) | JP2001504329A (en) |
| KR (1) | KR20000052831A (en) |
| CN (1) | CN1235513A (en) |
| AR (1) | AR009600A1 (en) |
| AU (1) | AU734052B2 (en) |
| BR (1) | BR9712587A (en) |
| CA (1) | CA2265523A1 (en) |
| EE (1) | EE9900176A (en) |
| ID (1) | ID22065A (en) |
| IL (1) | IL129397A0 (en) |
| IS (1) | IS5005A (en) |
| NO (1) | NO991995L (en) |
| NZ (1) | NZ334568A (en) |
| PL (1) | PL333169A1 (en) |
| SA (1) | SA98180918A (en) |
| SK (1) | SK34699A3 (en) |
| TR (1) | TR199900940T2 (en) |
| WO (1) | WO1998018323A1 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406703B1 (en) | 1993-07-27 | 2002-06-18 | Csl Limited | Treatment of H. pylori associated gastroduodenal disease |
| KR100333113B1 (en) * | 1993-07-27 | 2002-11-27 | 시에스엘 리미티드 | Treatment of h. pylori associated gastroduodenal disease |
| DE19730425A1 (en) | 1997-07-16 | 1999-01-21 | Henkel Teroson Gmbh | Heat-curing laundry-resistant shell sealant |
| JP2002524035A (en) * | 1998-07-27 | 2002-08-06 | コナート ラボラトリーズ リミテッド | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| SE9901548D0 (en) * | 1999-04-29 | 1999-04-29 | Astra Ab | Helicobacter pylori antigens |
| GB9914945D0 (en) * | 1999-06-25 | 1999-08-25 | Smithkline Beecham Biolog | Novel compounds |
| AUPQ347199A0 (en) * | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
| CN100482790C (en) | 2000-03-08 | 2009-04-29 | 诺维信公司 | Variants with altered properties |
| GB0010370D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
| GB0010371D0 (en) * | 2000-04-29 | 2000-06-14 | Astrazeneca Ab | Helicobacter pylori antigens |
| US9359627B2 (en) | 2011-03-17 | 2016-06-07 | National University Corporation Mie University | Antibody production method |
| US10828358B2 (en) * | 2015-12-14 | 2020-11-10 | Technische Universität München | Helicobacter pylori vaccines |
| CN115724922B (en) * | 2022-07-19 | 2023-08-22 | 四川大学华西医院 | Helicobacter pylori vaccine recombinant protein antigen TonB, preparation method and application thereof |
| CN115581201A (en) * | 2022-08-26 | 2023-01-10 | 云南省农业科学院花卉研究所 | Diploid rose F induced by stem segment as explant 1 -61 plant regeneration method |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9300139L (en) * | 1993-01-19 | 1994-07-20 | Medicarb Ab | Preparation of a new drug |
-
1997
- 1997-10-28 IL IL12939797A patent/IL129397A0/en unknown
- 1997-10-28 CA CA002265523A patent/CA2265523A1/en not_active Abandoned
- 1997-10-28 WO PCT/US1997/019575 patent/WO1998018323A1/en not_active Application Discontinuation
- 1997-10-28 KR KR1019990703660A patent/KR20000052831A/en not_active Application Discontinuation
- 1997-10-28 AU AU50933/98A patent/AU734052B2/en not_active Ceased
- 1997-10-28 BR BR9712587-3A patent/BR9712587A/en not_active IP Right Cessation
- 1997-10-28 CN CN97199233A patent/CN1235513A/en active Pending
- 1997-10-28 EP EP97913847A patent/EP0973394A4/en not_active Withdrawn
- 1997-10-28 EE EEP199900176A patent/EE9900176A/en unknown
- 1997-10-28 AR ARP970105002A patent/AR009600A1/en not_active Application Discontinuation
- 1997-10-28 NZ NZ334568A patent/NZ334568A/en unknown
- 1997-10-28 PL PL97333169A patent/PL333169A1/en unknown
- 1997-10-28 JP JP52071098A patent/JP2001504329A/en active Pending
- 1997-10-28 SK SK346-99A patent/SK34699A3/en unknown
- 1997-10-28 TR TR1999/00940T patent/TR199900940T2/en unknown
- 1997-10-28 ID IDW990160A patent/ID22065A/en unknown
-
1998
- 1998-02-28 SA SA98180918A patent/SA98180918A/en unknown
-
1999
- 1999-03-18 IS IS5005A patent/IS5005A/en unknown
- 1999-04-27 NO NO991995A patent/NO991995L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001504329A (en) | 2001-04-03 |
| NO991995L (en) | 1999-06-28 |
| CA2265523A1 (en) | 1998-05-07 |
| AU5093398A (en) | 1998-05-22 |
| ID22065A (en) | 1999-08-26 |
| IS5005A (en) | 1999-03-18 |
| SK34699A3 (en) | 2000-04-10 |
| KR20000052831A (en) | 2000-08-25 |
| CN1235513A (en) | 1999-11-17 |
| EE9900176A (en) | 1999-12-15 |
| NO991995D0 (en) | 1999-04-27 |
| AU734052B2 (en) | 2001-05-31 |
| IL129397A0 (en) | 2000-02-17 |
| WO1998018323A1 (en) | 1998-05-07 |
| TR199900940T2 (en) | 1999-09-21 |
| EP0973394A4 (en) | 2005-03-30 |
| EP0973394A1 (en) | 2000-01-26 |
| NZ334568A (en) | 2000-04-28 |
| BR9712587A (en) | 1999-10-26 |
| SA98180918A (en) | 2005-12-03 |
| PL333169A1 (en) | 1999-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR009600A1 (en) | SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME. | |
| AR004668A1 (en) | A PURIFIED ISOLATED NUCLEIC ACID, A RECOMBINING VECTOR OF EXPRESSION THAT UNDERSTANDS IT, A CELL THAT INCLUDES SUCH A VECTOR, A METHOD FOR THE PRODUCTION OF A H.PYLORI POLYPEPTIDE, A COMPOSITION OF A VACCINE, A PREPARED COMPOSITION PURIFIED BY H. | |
| AR067658A2 (en) | AN IMMUNOGENIC POLYPEPTIDE, A POLINUCLEOTIDE CODIFYING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE POLYPEPTIDES AND POLYNUCLEOTIDES, XPRESSION VECTORS, VACCINES, A METHOD FOR THE PREPARATION OF SUCH POLYPEPTIDE DIFFUSED POLIPEPTIDE. | |
| KR870700019A (en) | Recombinant alveolar surfactant protein | |
| AR006999A1 (en) | AN IMMUNOGENIC, THERAPEUTIC OR PROPHYLACTIC COMPOSITION, INCLUDING AN ISOLATED POLYPEPTIDE, AN ISOLATED ANTIBODY THAT IS LINKED TO SUCH A POLYPEPTIDE AND A VACCINE THAT UNDERSTANDS IT. | |
| ATE108438T1 (en) | URETHANE PROTECTED AMINO ACIDS N- CARBOXYAN HYDRIDES. | |
| BR9306272A (en) | Peptide and pharmaceutical composition | |
| DK611386A (en) | RECOMBINANT HUMANT FSH, PROCEDURE FOR PREPARING IT AND VECTORS AND CELLS FOR USING THE PROCEDURE | |
| NZ332565A (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
| AR013618A1 (en) | METHOD AND COMPOSITIONS FOR THE DISTRIBUTION AND EXPRESSION OF NUCLEIC ACIDS OF INTERFERON | |
| DK0463053T3 (en) | Preparation and use of anthelmintic agents and protective immunogens | |
| NZ335633A (en) | Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases | |
| FI791565A (en) | PHARMACEUTICAL COMPOSITION INNALOLLANDE PROSTAGLANDINFOERENINGAR | |
| ATE110389T1 (en) | THF COMPOSITIONS. | |
| DK527187D0 (en) | GONADOLIBERINE ANALOGUE, PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS MEDICINES | |
| DE3686257D1 (en) | PRODUCTION OF POLYPEPTIDES. | |
| DK1612555T3 (en) | Cryptic peptides for use in inducing immunological tolerance | |
| ID23052A (en) | VACCINE COMPOSITION THAT CONTAINS POLYPEPTIDE OF FLGE HELICOBACTER PYLORI | |
| MX9709846A (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics. | |
| DE69012328D1 (en) | SRIF RELATED PEPTIDES AND THEIR USE. | |
| TH43867A (en) | Nucleic acid sequence and amino acids associated with Helicobacter pyroli and their vaccine composition. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |